[Risk factors of bloodstream infections associated with parenteral nutrition in pediatric patients]

P Balboa Cardemil1, C Castillo Durán

  • 1Departamento de Pediatría, Facultad de Medicina, Campus Norte, Universidad de Chile, Hospital Roberto del Río, Santiago, Chile. pvbalboa@gmail.com

Nutricion Hospitalaria
|March 14, 2012
PubMed

Insights

Bloodstream infections (BSI) linked to parenteral nutrition (PN) in children are primarily associated with longer PN duration. Malnutrition is a secondary risk factor for these infections in pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Nutrition
  • Hospital Epidemiology

Background:

  • Parenteral nutrition (PN) is essential for pediatric patients but carries a risk of bloodstream infections (BSI).
  • Identifying key risk factors for PN-associated BSI is crucial for patient safety, especially in resource-limited settings.
  • Previous research has not clearly established the most significant risk factors for PN-associated BSI in Chile.

Purpose of the Study:

  • To investigate and identify the primary risk factors for bloodstream infections (BSI) associated with parenteral nutrition (PN) in pediatric patients.
  • To analyze data from public hospitals in Santiago, Chile, to understand local epidemiology of PN-associated BSI.
  • To inform clinical practice and improve preventative strategies for BSI in children receiving PN.

Main Methods:

  • A retrospective case-control study was conducted in two public hospitals in Santiago, Chile, from January 2002 to December 2005.
  • Patients receiving PN were analyzed, with cases defined as those with positive blood cultures during PN and controls as those with negative blood cultures.
  • Statistical analyses included parametric, nonparametric, and stepwise logistic regression to identify significant risk factors.

Main Results:

  • The study identified 58 cases and 130 controls. Patients with BSI received PN for a significantly longer duration (24 days vs. 10 days, p < 0.001).
  • A higher rate of malnutrition was observed in the case group (44.4% vs. 31%, p < 0.05).
  • Logistic regression analysis revealed that the duration of PN (in weeks) was the only statistically significant predictor of BSI (OR: 1.55, p < 0.05).

Conclusions:

  • Longer duration of parenteral nutrition is a significant risk factor for bloodstream infections in pediatric patients in Santiago, Chile.
  • The child's nutritional status (compromise) is a less significant, but still relevant, contributing factor to PN-associated BSI.
  • Findings underscore the importance of monitoring PN duration and nutritional status to prevent BSI in vulnerable pediatric populations.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...